Mylan Investor Relations

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time.

Mylan (MYL) NASDAQ | Jan 18, 2018, 4:00 ET

Day High: N/A
Day Low: N/A
Volume: N/A
52-Week High: 47.25
52-Week Low: 29.39


36th Annual J.P. Morgan Healthcare Conference Q&A Session

January 09, 2018

36th Annual J.P. Morgan Healthcare Conference
Location: San Francisco

January 09, 2018

CANCELLED - Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
Location: Boston

January 04, 2018


In order to set new standards in healthcare, we have leaders dedicated to helping people gain access to affordable medicine on a global scale. Learn about the passionate people who carry out Mylan’s day-to-day business and bring quality to our facilities.

Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.